Morgan Stanley Maintains Equal-Weight on Ovintiv, Raises Price Target to $72
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE:OVV) with a Equal-Weight and raises the price target from $71 to $72.
Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE:OVV) with a Equal-Weight and raises the price target from $71 to $72.
